Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | Phase 2 | ClinicalTrials |
| Neuritis; Optic Neuritis | Phase 1 | ClinicalTrials |
| Diabetes Mellitus; Diabetes Mellitus, Type 2 | Phase 2 | ClinicalTrials |
| Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Sclerosis | Phase 2/Phase 3 | ClinicalTrials |
| Polyneuropathies | Phase 2/Phase 3 | ClinicalTrials |
| Hypercholesterolemia | Phase 2 | ClinicalTrials |
| Adrenoleukodystrophy | Phase 2 | ClinicalTrials |
| Multiple Sclerosis; Sclerosis | Phase 2 | ClinicalTrials |
CONTENTS